Background Adalimumab is a subcutaneous anti-tumour necrosis factor antibody therapy
used in the treatment of numerous pathologies related to rheumatology, dermatology and …

Background Albumin has been widely used in clinical practise. While some of these
indications are supported by the results of randomised studies, others are based only on …

Background Adalimumab and ustekinumab have demonstrated a high level of efficacy in the
treatment of moderate-severe psoriasis in randomised controlled trials. There are, however …

Background Glatiramer acetate (GA) is a firstline therapy approved for the treatment of
relapsing remitting multiple sclerosis (RRMS). GA 20 mg/mL (GA20) administered once daily …

Background Bosentan and ambrisentan, endothelin receptor antagonists, are used as
treatment for pulmonary arterial hypertension (PAH), alone or in combination. It is known that …

Background During the last decade healthcare systems have developed different strategies
for containing drug costs. Among others, in Spain the Ministry of Health together with …

[Therapeutic use of hemoderivatives] [Therapeutic use of hemoderivatives] Sangre (Barc). 1997
Oct;42(5):423-7. [Article in Spanish] Authors N Yurrebaso Eguilior 1 , FM Mota Villaplana, JB …